Evidence that MCP-1 may determine bone loss responses to parathyroid hormone
In a new study New York University College of Dentistry (NYU Dentistry) researchers investigating the catabolic effect of parathyroid hormone (PTH) in hyperparathyroidism (HPT) showed, for the first time, that monocyte chemoattractant protein-1 (MCP-1) is required for catabolic responses to PTH. HPT is a condition in which an abnormally high concentration of PTH in the […]
